Algenis SpA
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy (NCT05052398) | Algenis SpA | 2021-01-14 |
| Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study (NCT04799041) | Algenis SpA | 2019-10-11 |
Track Algenis SpA automatically
Every clearance here is in the API, with alerts when new ones post.